Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 29  •  12:41PM ET
138.01
Dollar change
-0.86
Percentage change
-0.62
%
Index
RUT
P/E
74.52
EPS (ttm)
1.85
Insider Own
1.92%
Shs Outstand
24.99M
Perf Week
5.10%
Market Cap
3.45B
Forward P/E
14.84
EPS next Y
9.30
Insider Trans
-1.44%
Shs Float
24.51M
Perf Month
19.54%
Enterprise Value
4.50B
PEG
1.51
EPS next Q
1.91
Inst Own
102.10%
Perf Quarter
-8.35%
Income
46.34M
P/S
1.60
EPS this Y
5.28%
Inst Trans
-0.79%
Perf Half Y
-9.15%
Sales
2.16B
P/B
1.63
EPS next Y
13.79%
ROA
1.13%
Perf YTD
-3.27%
Book/sh
84.50
P/C
11.96
EPS next 5Y
9.85%
ROE
2.26%
52W High
160.29 -13.90%
Perf Year
2.66%
Cash/sh
11.54
P/FCF
41.71
EPS past 3/5Y
- -62.61%
ROIC
1.36%
52W Low
107.00 28.98%
Perf 3Y
-20.34%
Dividend Est.
-
EV/EBITDA
14.31
Sales past 3/5Y
-0.68% 11.90%
Gross Margin
34.81%
Volatility
3.94% 4.11%
Perf 5Y
-33.67%
Dividend TTM
-
EV/Sales
2.09
EPS Y/Y TTM
148.96%
Oper. Margin
5.09%
ATR (14)
5.30
Perf 10Y
32.66%
Dividend Ex-Date
-
Quick Ratio
1.13
Sales Y/Y TTM
-10.76%
Profit Margin
2.15%
RSI (14)
66.97
Dividend Gr. 3/5Y
- -
Current Ratio
2.30
EPS Q/Q
289.73%
SMA20
9.26%
Beta
0.78
Payout
0.00%
Debt/Eq
0.64
Sales Q/Q
-12.19%
SMA50
9.61%
Rel Volume
0.52
Prev Close
138.87
Employees
13000
LT Debt/Eq
0.62
SMA200
3.09%
Avg Volume
291.77K
Price
138.01
IPO
Mar 31, 1992
Option/Short
Yes / Yes
Trades
Volume
78,148
Change
-0.62%
Date Action Analyst Rating Change Price Target Change
May-27-26Upgrade Needham Hold → Buy $165
Aug-15-25Initiated Piper Sandler Overweight $145
Mar-12-25Upgrade Raymond James Outperform → Strong Buy $205 → $197
Dec-11-24Upgrade Jefferies Hold → Buy $200
Oct-14-24Initiated Jefferies Hold $183
Jun-21-24Initiated Needham Hold
Jun-17-24Upgrade Raymond James Mkt Perform → Outperform $135
Nov-08-22Downgrade Raymond James Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
May-07-26 05:07PM
04:05PM
Apr-23-26 08:30AM
Mar-03-26 07:24PM
Feb-23-26 08:30AM
08:30AM Loading…
Feb-20-26 08:30AM
03:58AM
12:04AM
Feb-19-26 10:07PM
06:30PM
05:50PM
05:20PM
05:07PM
04:05PM
Feb-17-26 10:04PM
08:57PM Loading…
Feb-13-26 08:57PM
Feb-05-26 08:30AM
Jan-22-26 09:21PM
Jan-15-26 11:31PM
07:49AM
Dec-31-25 08:30AM
Dec-15-25 11:03PM
Nov-27-25 10:31PM
Nov-20-25 08:30AM
Nov-13-25 12:35AM
Nov-07-25 01:11PM
11:46AM
09:28AM
12:02AM
Nov-06-25 07:00PM
06:03PM Loading…
06:03PM
04:17PM
04:05PM
Nov-05-25 06:25PM
Nov-04-25 10:12PM
Oct-29-25 08:50AM
Oct-27-25 11:32PM
Oct-23-25 08:30AM
Sep-05-25 12:45PM
Sep-04-25 12:43AM
Sep-01-25 09:51AM
Aug-21-25 08:30AM
Aug-15-25 09:32AM
Aug-14-25 01:35AM
Aug-11-25 09:30AM
Aug-08-25 12:21PM
09:27AM
04:33AM
Aug-07-25 06:40PM
05:33PM
04:05PM
Aug-05-25 11:07PM
Aug-04-25 04:08AM
Jul-25-25 11:15AM
Jul-24-25 08:30AM
Jul-18-25 11:07AM
Jul-01-25 05:34AM
01:32AM
Jun-18-25 11:31PM
Jun-10-25 12:03AM
Jun-04-25 07:27AM
May-09-25 11:15AM
03:38AM
12:36AM
May-08-25 06:45PM
05:41PM
04:05PM
May-07-25 09:54AM
04:55AM
May-01-25 08:30AM
Apr-29-25 05:59AM
Apr-24-25 08:30AM
Apr-10-25 01:20PM
Apr-09-25 06:33AM
Apr-08-25 12:04PM
Apr-07-25 08:00AM
Mar-25-25 05:03AM
Mar-24-25 08:30AM
Mar-21-25 07:04AM
Mar-07-25 08:40AM
Mar-06-25 08:02AM
Mar-03-25 07:19PM
Feb-28-25 07:28AM
02:33AM
Feb-27-25 09:06PM
06:20PM
05:19PM
05:10PM
04:05PM
Feb-26-25 08:03AM
07:22AM
Feb-14-25 04:04AM
04:01AM
Feb-13-25 04:05PM
04:05PM
04:02AM
04:01AM
Jan-03-25 08:30AM
Nov-13-24 02:16AM
02:04AM
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
CEO & Chairman of the BoardMr. Vivek Jain
PresidentMr. Daniel Woolson
CFO & TreasurerMr. Brian Michael Bonnell
Chief Operating OfficerMr. Christian B. Voigtlander
Corporate VPMs. Virginia Ruth Sanzone
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANIEL WOOLSONOfficerMay 22 '26Proposed Sale132.212,123280,685May 22 04:35 PM
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22 03:47 PM
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15 12:19 PM
VIRGINIA SANZONEOfficerMay 14 '26Proposed Sale124.082,447303,624May 14 06:48 PM
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.001,25404,539May 13 09:29 PM
Hernandez LaurieDirectorMay 13 '26Option Exercise0.001,25404,862May 13 09:20 PM
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.001,25405,249May 13 09:11 PM
Abbey DonaldDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:52 PM
Hoffmeister David FDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:38 PM
Greenberg David C.DirectorMay 12 '26Option Exercise101.062,424244,96910,384May 13 08:31 PM
Greenberg David C.DirectorMay 13 '26Option Exercise0.001,25409,214May 13 08:31 PM
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13 08:31 PM
DAVID C GREENBERGDirectorMay 12 '26Proposed Sale122.912,424297,934May 12 05:39 PM
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0014,648051,154Mar 16 04:34 PM
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.002,924025,897Mar 16 04:33 PM
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.001,30006,044Mar 16 04:32 PM
Sanzone Virginia RuthVP, General CounselMar 15 '26Option Exercise0.007,324024,330Mar 16 04:31 PM
Jain VivekChairman and CEOMar 15 '26Option Exercise0.0021,9720134,106Mar 16 04:30 PM
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0014,648076,097Mar 16 04:28 PM
Bonnell Brian MichaelChief Financial OfficerMar 08 '26Option Exercise0.0071,7570104,364Mar 09 04:32 PM
Bonnell Brian MichaelChief Financial OfficerMar 07 '26Option Exercise0.003,522033,870Mar 09 04:32 PM
Jain VivekChairman and CEOMar 08 '26Option Exercise0.00107,6350176,506Mar 09 04:21 PM
Jain VivekChairman and CEOMar 07 '26Option Exercise0.005,282071,790Mar 09 04:21 PM
Sousa BenChief Information OfficerMar 08 '26Option Exercise0.008,13408,283Mar 09 04:19 PM
Sousa BenChief Information OfficerMar 07 '26Option Exercise0.001,40901,888Mar 09 04:19 PM
Sanzone Virginia RuthVP, General CounselMar 08 '26Option Exercise0.0027,106030,424Mar 09 04:18 PM
Sanzone Virginia RuthVP, General CounselMar 07 '26Option Exercise0.002,34807,804Mar 09 04:18 PM
Woolson DanielVP, GM-Infusion CapitalMar 08 '26Option Exercise0.0018,300028,327Mar 09 04:15 PM
Woolson DanielVP, GM-Infusion CapitalMar 07 '26Option Exercise0.001,585012,882Mar 09 04:15 PM
Voigtlander Christian B.Chief Operating OfficerMar 08 '26Option Exercise0.0071,757079,421Mar 09 04:14 PM
Voigtlander Christian B.Chief Operating OfficerMar 07 '26Option Exercise0.003,52209,610Mar 09 04:14 PM
DANIEL WOOLSONOfficerNov 25 '25Proposed Sale152.352,897441,364Nov 25 04:09 PM
Woolson DanielVP, GM-Infusion CapitalNov 25 '25Sale152.352,897441,36411,297Nov 25 03:18 PM
FINNEY ELISHA WDirectorNov 11 '25Option Exercise103.761,285133,3325,280Nov 12 10:59 AM
FINNEY ELISHA WDirectorNov 11 '25Sale140.421,285180,4403,995Nov 12 10:59 AM
Sanzone Virginia RuthVP, General CounselNov 11 '25Sale142.34930132,3815,456Nov 12 10:55 AM
VIRGINIA SANZONEOfficerNov 11 '25Proposed Sale142.34930132,381Nov 12 10:27 AM
ELISHA W FINNEYDirectorNov 11 '25Proposed Sale140.421,285180,440Nov 12 09:05 AM
Greenberg David C.DirectorAug 27 '25Buy126.421,200151,6987,960Aug 27 05:51 PM
Jain VivekChairman and CEOAug 14 '25Buy112.8421,9292,474,375130,149Aug 14 07:07 PM
VIRGINIA SANZONEOfficerMay 30 '25Proposed Sale133.6270093,537May 30 04:17 PM
Sanzone Virginia RuthVP, General CounselMay 30 '25Sale133.6270093,5376,386May 30 02:34 PM